All data are based on the daily closing price as of May 8, 2026
s
Suzuken
9987.TSE
34.50 USD
-0.41
-1.17%
Overview
Last close
34.50 usd
Market cap
2.33B usd
52 week high
42.29 usd
52 week low
29.12 usd
Target price
42.34 usd
Valuation
P/E
12.8206
Forward P/E
11.0742
Price/Sales
0.1494
Price/Book Value
0.9023
Enterprise Value
937.22M usd
EV/Revenue
0.0606
EV/EBITDA
2.5881
Key financials
Revenue TTM
15.62B usd
Gross Profit TTM
1.21B usd
EBITDA TTM
318.01M usd
Earnings per Share
2.69 usd
Dividend
0.64 usd
Total assets
8.35B usd
Net debt
-1.11B usd
About
Suzuken Co., Ltd., together with its subsidiaries, primarily engages in the distribution of pharmaceuticals in Japan and internationally. The company operates in four segments: Pharmaceutical Distribution, Healthcare Product Development, Community Healthcare and Nursing Care Support, and Healthcare Related Services. The Pharmaceutical Distribution Business segment purchases ethical drugs, diagnostic agents, medical equipment, medical materials, and medical food products, as well as pharmaceutical and medical equipment manufacturers, and supplies medical institutions, and insurance pharmacies. The Healthcare Product Development segment offers ethical drugs, diagnostic reagents, and medical devices and materials. The Community Healthcare and Nursing Care Support segment provides a range of pharmacy and nursing care services. The Healthcare Related Services segment offers contract distribution for manufacturers and contract distribution of orphan drugs. Suzuken Co., Ltd. was founded in 1932 and is headquartered in Nagoya, Japan.